Which hedge funds own 4XC1? KALVISTA PHARMACEUTICALS INC, Q2 2026 13F holders
0 tracked hedge funds disclosed a position in 4XC1 (KALVISTA PHARMACEUTICALS INC) in their Q2 2026 13F filings, worth $0 in total. 47 exited: Squadron Capital Management LLC, Silverarc Capital Management, LLC, Elmind Capital, LP.
- 0
- Holders
- 0
- New this quarter
- 47
- Exited this quarter
- $0
- Combined value
- 0.0%
- Share of managers holding
Holders, Q2 2026
Exited since the previous filing
Ownership over time
By quarter
| Quarter | Holders | Managers filing | Share holding | Combined value |
|---|---|---|---|---|
| Q2 2026 | 0 | 1,205 | 0.0% | $0 |
| Q1 2026coverage widened | 47 | 1,209 | 3.9% | $822m |
| Q4 2025 | 4 | 71 | 5.6% | $148m |
| Q3 2025 | 2 | 73 | 2.7% | $81.5m |
| Q2 2025 | 2 | 73 | 2.7% | $77.7m |
| Q1 2025 | 2 | 73 | 2.7% | $75.4m |
| Q4 2024 | 2 | 74 | 2.7% | $52.5m |
| Q3 2024 | 2 | 73 | 2.7% | $55.8m |
| Q2 2024 | 2 | 73 | 2.7% | $51.2m |
| Q1 2024 | 3 | 73 | 4.1% | $54.4m |
| Q4 2023 | 3 | 73 | 4.1% | $37.6m |
| Q3 2023 | 2 | 73 | 2.7% | $24.0m |
| Q2 2023 | 3 | 73 | 4.1% | $20.6m |
| Q1 2023 | 2 | 73 | 2.7% | $16.2m |
| Q4 2022 | 3 | 73 | 4.1% | $11.9m |
| Q3 2022 | 4 | 74 | 5.4% | $38.3m |
| Q2 2022 | 3 | 74 | 4.1% | $31.9m |
| Q1 2022 | 4 | 74 | 5.4% | $61.8m |
| Q4 2021 | 4 | 74 | 5.4% | $50.8m |
| Q3 2021 | 4 | 71 | 5.6% | $63.3m |
| Q2 2021 | 3 | 71 | 4.2% | $77.2m |
| Q1 2021 | 4 | 70 | 5.7% | $43.4m |
| Q4 2020 | 2 | 71 | 2.8% | $6.8m |
| Q3 2020 | 1 | 68 | 1.5% | $3.9m |
| Q2 2020 | 2 | 68 | 2.9% | $3.5m |
| Q1 2020 | 2 | 68 | 2.9% | $1.2m |
| Q4 2019 | 0 | 67 | 0.0% | $0 |
| Q3 2019 | 2 | 60 | 3.3% | $1.2m |
| Q2 2019 | 1 | 60 | 1.7% | $3.6m |
| Q1 2019 | 2 | 60 | 3.3% | $45.8m |
| Q4 2018 | 2 | 60 | 3.3% | $32.0m |
| Q3 2018 | 3 | 59 | 5.1% | $38.9m |
| Q2 2018 | 2 | 59 | 3.4% | $12.0m |
| Q1 2018 | 2 | 59 | 3.4% | $14.1m |
| Q4 2017 | 2 | 59 | 3.4% | $14.9m |
| Q3 2017 | 1 | 56 | 1.8% | $4.3m |
| Q2 2017 | 1 | 56 | 1.8% | $4.3m |
| Q1 2017 | 1 | 56 | 1.8% | $4.6m |
| Q4 2016 | 1 | 56 | 1.8% | $4.2m |
Who discovered 4XC1 first?
Earliest meaningful positions among the 6 tracked managers seen opening 4XC1 since Q4 2016.
| RA Capital Management, L.P. | Q4 2016 | 0.6% | Exited by Q2 2022 | – |
| Montanova Capital, LLC | Q1 2020 | 0.02% | Exited by Q2 2026 | +492% |
Stock since is the split-adjusted change in the quarter-end price, excluding dividends, from the first reported quarter: the price the 13F filings themselves imply (value ÷ shares), blank across any gap that cannot be accounted for. It describes the stock, not the return any manager earned.
44 already held it when coverage began
ADAR1 Capital Management, LLC (Q1 2026), AQR Capital Management LLC (Q1 2026), Armistice Capital, LLC (Q1 2026), Atom Investors LP (Q1 2026), Balyasny Asset Management L.P. (Q1 2026), Birchview Capital, LP (Q1 2026), Boxer Capital Management, LLC (Q1 2026), Brevan Howard Capital Management LP (Q1 2026), Campbell & CO Investment Adviser LLC (Q1 2026), Catalio Capital Management, LP (Q1 2026), CenterBook Partners LP (Q1 2026), Citadel Advisors LLC (Q1 2026), DAFNA Capital Management LLC (Q1 2026), Elmind Capital, LP (Q1 2026), Engineers Gate Manager LP (Q1 2026), ExodusPoint Capital Management, LP (Q1 2026), Frazier Life Sciences Management, L.P. (Q1 2026), Freestone Grove Partners LP (Q1 2026), Great Point Partners LLC (Q1 2026), Ikarian Capital, LLC (Q1 2026), Ishara Investments LP (Q1 2026), Kynam Capital Management, LP (Q1 2026), Marshall Wace, LLP (Q1 2026), Millennium Management LLC (Q1 2026), NEXTBio Capital Management LP (Q1 2026), Octagon Capital Advisors LP (Q1 2026), Orbimed Advisors LLC (Q1 2026), Parkman Healthcare Partners LLC (Q1 2026), Persistent Asset Partners Ltd (Q1 2026), Quarry LP (Q1 2026), Qube Research & Technologies Ltd (Q1 2026), Schonfeld Strategic Advisors LLC (Q1 2026), Seven Fleet Capital Management LP (Q1 2026), Silverarc Capital Management, LLC (Q1 2026), Spruce Street Capital LP (Q1 2026), Squadron Capital Management LLC (Q1 2026), Squarepoint Ops LLC (Q1 2026), Trexquant Investment LP (Q1 2026), Two Sigma Investments, LP (Q1 2026), Venrock Adviser, LLC (Q1 2026), Verition Fund Management LLC (Q1 2026), Vestal Point Capital, LP (Q1 2026), Walleye Capital LLC (Q1 2026), Y-Intercept (Hong Kong) Ltd (Q1 2026)